Literature DB >> 26928821

Consumer Perceptions of Interactions With Primary Care Providers After Direct-to-Consumer Personal Genomic Testing.

Cathelijne H van der Wouden, Deanna Alexis Carere, Anke H Maitland-van der Zee, Mack T Ruffin, J Scott Roberts, Robert C Green.   

Abstract

BACKGROUND: Direct-to-consumer (DTC) personal genomic testing (PGT) allows individuals to learn about their genetic makeup without going through a physician, but some consumers share their results with their primary care provider (PCP).
OBJECTIVE: To describe the characteristics and perceptions of DTC PGT consumers who discuss their results with their PCP.
DESIGN: Longitudinal, prospective cohort study.
SETTING: Online survey before and 6 months after results. PARTICIPANTS: DTC PGT consumers. MEASUREMENTS: Consumer satisfaction with the DTC PGT experience; whether and, if so, how many results could be used to improve health; how many results were not understood; and beliefs about the PCP's understanding of genetics. Participants were asked with whom they had discussed their results. Genetic reports were linked to survey responses.
RESULTS: Among 1026 respondents, 63% planned to share their results with a PCP. At 6-month follow-up, 27% reported having done so, and 8% reported sharing with another health care provider only. Common reasons for not sharing results with a health care provider were that the results were not important enough (40%) or that the participant did not have time to do so (37%). Among participants who discussed results with their PCP, 35% were very satisfied with the encounter, and 18% were not at all satisfied. Frequently identified themes in participant descriptions of these encounters were actionability of the results or use in care (32%), PCP engagement or interest (25%), and lack of PCP engagement or interest (22%). LIMITATION: Participants may not be representative of all DTC PGT consumers.
CONCLUSION: A comprehensive picture of DTC PGT consumers who shared their results with a health care provider is presented. The proportion that shares results is expected to increase with time after testing as consumers find opportunities for discussion at later appointments or if results become relevant as medical needs evolve. PRIMARY FUNDING SOURCE: National Institutes of Health.

Entities:  

Mesh:

Year:  2016        PMID: 26928821     DOI: 10.7326/M15-0995

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  43 in total

Review 1.  Genetic Testing in Clinical Settings.

Authors:  Nora Franceschini; Amber Frick; Jeffrey B Kopp
Journal:  Am J Kidney Dis       Date:  2018-04-11       Impact factor: 8.860

Review 2.  First Responder to Genomic Information: A Guide for Primary Care Providers.

Authors:  Susanne B Haga
Journal:  Mol Diagn Ther       Date:  2019-08       Impact factor: 4.074

3.  Consumer Perspectives on Access to Direct-to-Consumer Genetic Testing: Role of Demographic Factors and the Testing Experience.

Authors:  Sarah E Gollust; Stacy W Gray; Deanna Alexis Carere; Barbara A Koenig; Lisa Soleymani Lehmann; Amy L McGUIRE; Richard R Sharp; Kayte Spector-Bagdady; N A Wang; Robert C Green; J Scott Roberts
Journal:  Milbank Q       Date:  2017-06       Impact factor: 4.911

Review 4.  Physician preparedness for big genomic data: a review of genomic medicine education initiatives in the United States.

Authors:  Caryn Kseniya Rubanovich; Cynthia Cheung; Jess Mandel; Cinnamon S Bloss
Journal:  Hum Mol Genet       Date:  2018-08-01       Impact factor: 6.150

5.  Primary care providers' experiences with and perceptions of personalized genomic medicine.

Authors:  June C Carroll; Tutsirai Makuwaza; Donna P Manca; Nicolette Sopcak; Joanne A Permaul; Mary Ann O'Brien; Ruth Heisey; Elizabeth A Eisenhauer; Julie Easley; Monika K Krzyzanowska; Baukje Miedema; Sandhya Pruthi; Carol Sawka; Nancy Schneider; Jonathan Sussman; Robin Urquhart; Catarina Versaevel; Eva Grunfeld
Journal:  Can Fam Physician       Date:  2016-10       Impact factor: 3.275

6.  Sequencing Newborns: A Call for Nuanced Use of Genomic Technologies.

Authors:  Josephine Johnston; John D Lantos; Aaron Goldenberg; Flavia Chen; Erik Parens; Barbara A Koenig
Journal:  Hastings Cent Rep       Date:  2018-07       Impact factor: 2.683

7.  EMR documentation of physician-patient communication following genomic counseling for actionable complex disease and pharmacogenomic results.

Authors:  K Sweet; A C Sturm; T Schmidlen; S Hovick; J Peng; K Manickam; A Salikhova; J McElroy; L Scheinfeldt; A E Toland; J S Roberts; M Christman
Journal:  Clin Genet       Date:  2016-07-28       Impact factor: 4.438

8.  Transparency of genetic testing services for 'health, wellness and lifestyle': analysis of online prepurchase information for UK consumers.

Authors:  Jacqueline A Hall; Rena Gertz; Joan Amato; Claudia Pagliari
Journal:  Eur J Hum Genet       Date:  2017-05-03       Impact factor: 4.246

9.  "Bridge to the Literature"? Third-Party Genetic Interpretation Tools and the Views of Tool Developers.

Authors:  Sarah C Nelson; Stephanie M Fullerton
Journal:  J Genet Couns       Date:  2018-02-07       Impact factor: 2.537

10.  Utilization of Genetic Counseling after Direct-to-Consumer Genetic Testing: Findings from the Impact of Personal Genomics (PGen) Study.

Authors:  Diane R Koeller; Wendy R Uhlmann; Deanna Alexis Carere; Robert C Green; J Scott Roberts
Journal:  J Genet Couns       Date:  2017-05-16       Impact factor: 2.537

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.